text
"['\n1. 요약재무정보\n당사는 2018년 9월 19일 발표된 [제약ㆍ바이오 기업의 연구개발비 회계처리 관련 감독지침]을 고려, 개발비 자산화 시점의 회계처리 오류(무형자산 과대계상 및 경상연구개발비 과소계상 등)를 수정하였으며, 이에 따라 제27기(전전기) 재무재표는 소급 재작성되었습니다. \n가. 요약연결재무정보\n(단위: 원)\n구 분\n제29기 1분기\n제28기\n제27기\n(2019년 3월말)\n(2018년 12월말)\n(2017년 12월말)\n[유동자산]\n1,598,555,658,680\n1,664,478,918,682\n1,614,033,788,024\n ㆍ현금및현금성자산\n403,150,273,438\n410,547,608,852 \n419,205,662,651 \n ㆍ단기금융자산\n163,021,091,524\n121,636,304,845 \n138,717,014,000 \n ㆍ매출채권\n795,195,906,096\n807,711,314,915 \n828,394,032,126 \n ㆍ기타수취채권\n9,803,063,848\n124,267,624,254 \n3,211,880,582 \n ㆍ재고자산\n190,017,203,192\n163,114,412,936 \n199,481,840,555 \n ㆍ당기법인세자산\n9,523,563,778\n9,523,563,778 \n9,780,837,220 \n ㆍ기타유동자산\n27,844,556,804\n27,678,089,102 \n15,242,520,890 \n[비유동자산]\n1,903,551,053,692\n1,876,147,755,272\n1,701,493,916,629 \n ㆍ장기금융자산\n19,736,093,157\n18,989,084,041 \n15,686,919,883 \n ㆍ장기기타수취채권\n10,148,873,511\n10,287,886,409 \n8,562,470,441 \n ㆍ관계기업투자\n33,849,516,832\n28,003,078,925 \n17,006,445,302 \n ㆍ유형자산\n898,560,169,745\n881,437,749,875 \n844,212,382,151 \n ㆍ무형자산\n926,479,639,879\n922,339,536,489 \n809,790,408,679 \n ㆍ기타비유동자산\n14,776,760,568\n15,090,419,533 \n6,235,290,173 \n자산총계\n3,502,106,712,372\n3,540,626,673,954\n3,315,527,704,653\n[유동부채]\n623,127,673,543\n678,087,471,395 \n616,781,029,714 \n[비유동부채]\n235,228,865,079\n229,761,340,951 \n266,817,280,825 \n부채총계\n858,356,538,622\n907,848,812,346\n883,598,310,539\n[자본금]\n127,953,489,000\n125,456,133,000 \n122,666,424,000 \n[주식발행초과금]\n761,402,886,263\n761,047,500,208 \n741,748,885,673 \n[이익잉여금]\n1,763,261,115,453\n1,701,825,879,780 \n1,449,703,520,884 \n[기타포괄손익누계액]\n10,421,254,720\n9,970,124,880 \n8,720,587,567 \n[기타자본항목]\n-127,283,847,555\n(74,277,317,105)\n(13,947,041,218)\n[비지배지분]\n107,995,275,869\n108,755,540,845 \n123,037,017,208 \n자본총계\n2,643,750,173,750\n2,632,777,861,608 \n2,431,929,394,114 \n(2019.01.01~2019.03.31)\n(2018.01.01~2018.12.31)\n(2017.01.01~2017.1.31)\n매출액\n221,703,639,804\n982,074,959,799 \n949,079,965,214 \n영업이익\n77,355,873,875\n338,694,787,468 \n507,828,939,197 \n법인세비용차감전순이익\n81,405,629,369\n317,725,828,715 \n491,503,197,927 \n당기순이익\n63,021,445,145\n253,563,110,762 \n386,156,799,413 \n ㆍ지배기업소유주지분\n63,927,286,673\n261,841,768,570 \n382,467,031,688 \n ㆍ비지배지분\n(905,841,528)\n(8,278,657,808)\n3,689,767,725 \n ㆍ기본주당이익\n504\n2,059 \n3,010 \n연결에 포함된 회사수\n8\n8\n6\n나. 요약재무정보\n(단위: 원)\n구 분\n제29기 1분기\n제28기\n제27기\n(2019년 3월말)\n(2018년 12월말)\n(2017년 12월말)\n[유동자산]\n1,417,582,248,705\n1,482,507,600,161 \n1,421,211,524,496 \n ㆍ현금및현금성자산\n397,885,441,171\n399,558,425,745 \n413,501,866,488 \n ㆍ단기금융자산\n163,021,091,524\n121,636,304,845 \n138,402,014,000 \n ㆍ매출채권\n672,635,779,487\n689,472,264,429 \n713,489,012,682 \n ㆍ기타수취채권\n9,549,269,790\n123,885,214,981 \n3,133,116,830 \n ㆍ재고자산\n157,786,487,732\n125,915,033,826 \n141,164,307,648 \n ㆍ기타유동자산\n16,704,179,001\n22,040,356,335 \n11,521,206,848 \n[비유동자산]\n1,951,309,750,430\n1,925,650,130,627 \n1,738,404,699,064 \n ㆍ장기금융자산\n18,154,500,015\n17,407,490,899 \n14,354,326,741 \n ㆍ장기기타수취채권\n9,060,781,667\n9,141,484,165 \n7,169,744,638 \n ㆍ종속기업및관계기업투자\n292,262,166,532\n286,212,166,532 \n273,099,081,283 \n ㆍ유형자산\n692,742,266,384\n677,870,722,592 \n635,989,041,524 \n ㆍ무형자산\n918,862,247,950\n914,462,126,420 \n795,910,154,122 \n ㆍ투자부동산\n5,941,378,878\n5,982,493,446 \n6,147,170,166 \n ㆍ기타비유동자산\n14,286,409,004\n14,573,646,573 \n5,735,180,590 \n자산총계\n3,368,891,999,135\n3,408,157,730,788 \n3,159,616,223,560 \n[유동부채]\n494,596,599,522\n548,121,290,075 \n491,067,961,229 \n[비유동부채]\n221,845,397,101\n218,455,704,094 \n242,174,301,750 \n부채총계\n716,441,996,623\n766,576,994,169 \n733,242,262,979 \n[자본금]\n127,953,489,000\n125,456,133,000 \n122,666,424,000 \n[주식발행초과금]\n761,402,886,263\n761,047,500,208 \n741,748,885,673 \n[이익잉여금]\n1,891,542,601,322\n1,830,849,456,118 \n1,578,220,209,981 \n[기타포괄손익누계액]\n5,341,082,292\n5,011,173,208 \n4,512,733,369 \n[기타자본항목]\n-133,790,056,365\n(80,783,525,915)\n(20,774,292,442)\n자본총계\n2,652,450,002,512\n2,641,580,736,619 \n2,426,373,960,581 \n종속ㆍ관계ㆍ공동기업투자주식의 평가방법\n원가법\n원가법\n원가법\n(2019.01.01~2019.03.31)\n(2018.01.01~2018.12.31)\n(2017.01.01~2017.1.31)\n매출액\n191,506,967,194\n861,884,226,306 \n828,917,201,749 \n영업이익\n75,855,651,662\n334,976,430,311 \n499,135,008,050 \n법인세비용차감전순이익\n81,938,825,703\n312,274,618,195 \n489,959,261,511 \n당기순이익\n63,185,196,204\n254,360,949,995 \n383,515,712,006 \n ㆍ기본주당이익\n498\n2,000 \n3,018 \n']"
